The global biosimilars market is estimated to grow at a significant CAGR during the forecast period. The factors that drive the global biosimilars market include the increasing demand for biopharmaceuticals, rising geriatric population, and rapid R&D activities by the players in the field along with technological advancement. Moreover, according to the Pharmaceutical Research and Manufacturers of America (PhRMA) in 2016, the biopharmaceuticals manufacturers located in the US invested $90 billion for R&D activities.



Get Free Sample Copy @
https://www.omrglobal.com/request-sample/biosimilars-market



Moreover, the global biosimilars market is also gaining traction owing to the rise in R&D activities that promotes the utilization of alternative medications. With this move, the companies are targeting developing economies that are expected to attract a significant customer base.



Browse for Full Report at:
https://www.omrglobal.com/industry-reports/biosimilars-market



R&D by key players to significantly drive the biosimilars market :-

Some of the prominent players operating in the global biosimilars industry include Eli Lilly and Co., Merck & Co. Inc., Mylan NV, Biocon Ltd., Novartis International AG, Allergan Plc., Amgen Inc., F. Hoffmann-La Roche Ltd., Teva Pharmaceuticals Ltd., and Pfizer Inc., among others. These are the key companies providing various biosimilars in the market. These key manufacturers are adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others in order to thrive in a competitive environment.

In November 2018, Sandoz International GmbH, a Novartis company announced the R&D activities for the development of the biosimilar portfolio for unmet access and sustainability needs, and it will not buy US biosimilar rituximab, that will aid the company in enhancing its R&D activities.

In September 2019, Sandoz International GmbH, a Novartis company announced that the company has entered into an agreement regarding the proposed natalizumab biosimilar, which is in phase III of the clinical development. Thus, this created more growth opportunities for the company to grow its business.

In June 2019, Eli Lily Co. announced the launch of the lower-priced authorized biosimilar version of its diabetes treatment Humalog (insulin lispro) in the US. The launch of new products aids the company to improve its product portfolio.



Current Market Trends Covered in the Global Biosimilar Market Report:

1) Increased spending on the healthcare infrastructure by key companies and government is positively affecting the biosimilars market growth.

2) The oncology segment will account for a significant share in the market.

3) North America region will register a significant growth rate in biosimilars market globally


Global Biosimilars Market Report- Segmentation

By Product
Recombinant Non-Glycosylated Proteins
Recombinant Glycosylated Proteins

By Applications
Oncology
Chronic and Autoimmune Disease
Blood Disorders
Growth Hormone Deficiency
Other Diseases

Global Biosimilars Market – Segment by Region

North America
United States
Canada

Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific
China
Japan
India
Rest of Asia-Pacific

Rest of the World
Middle East & Africa
Latin America


Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.



For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/biosimilars-market



About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.



Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404